Publicacions en què col·labora amb ELIAS DELGADO ALVAREZ (12)

2024

  1. 100 Years since the Discovery of Insulin, from Its Discovery to the Insulins of the Future

    Biomedicines, Vol. 12, Núm. 3

  2. Hypoglycemia during hyperosmolar hyperglycemic crises is associated with long-term mortality

    Diabetology and Metabolic Syndrome, Vol. 16, Núm. 1

  3. Metformin and Glucose Concentration as Limiting Factors in Retinal Pigment Epithelial Cell Viability and Proliferation

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2023

  1. A long non-coding RNA that harbors a SNP associated with type 2 diabetes regulates the expression of TGM2 gene in pancreatic beta cells

    Frontiers in Endocrinology, Vol. 14

  2. Circulating miRNA expression in long-standing type 1 diabetes mellitus

    Scientific Reports, Vol. 13, Núm. 1

  3. Diabetic ketoacidosis at diagnosis of type 1 diabetes in Asturias (Spain) between 2011 and 2020: influence of symptom duration on prevalence of ketoacidosis and weight loss

    Revista espanola de salud publica, Vol. 97

  4. Diabetic ketoacidosis at diagnosis of type 1 diabetes in Asturias (Spain) between 2011 and 2020: influence of symptom duration on prevalence of ketoacidosis and weight loss

    Revista Espanola de Salud Publica, Vol. 97

  5. Hypoglycemia in patients with type 2 diabetes mellitus during hospitalization: associated factors and prognostic value

    Diabetology and Metabolic Syndrome, Vol. 15, Núm. 1

  6. Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020

    Diabetology and Metabolic Syndrome, Vol. 15, Núm. 1

  7. miR-24-3p and Body Mass Index as Type 2 Diabetes Risk Factors in Spanish Women 15 Years after Gestational Diabetes Mellitus Diagnosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

2022

  1. Correlation between glucose measurement parameters of continuous flash monitoring and HbA1c. Real life experience in Asturias

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 493-499

  2. Real-life effects of adding weekly subcutaneous semaglutide to insulin for the treatment of type 2 diabetes mellitus

    Revista Clinica Espanola, Vol. 222, Núm. 9, pp. 516-522